Table 3. Median survival of different subtypes of NTCCB in our study.
NTCCB: Non-transitional cell carcinoma of the bladder
NTCCB subtype | Median survival (months) |
Squamous cell carcinoma (n=14) | |
Localized (n=8) | 32 |
Locally advanced (n=4) | 13 |
Metastatic (n=2) | 12 |
Adenocarcinoma (n=13) | |
Localized (n=2) | 39 |
Locally advanced (n=1) | 15 |
Metastatic (n=10) | 11 |
Extra-adrenal phaeochromocytoma (n=1) | 57 |
Neuroendocrine tumor (n=2) | 10 |
Sarcomatoid carcinoma (n=1) | 9 |